Pay in 4 interest-free payments of $7.25 Learn more
Ships within 48 hours · Estimated delivery Nov 4 - Nov 9
Last updated: March 2026, including Phase 3 TRIUMPH-4 results and December 2025 Zepbound pricing
MOTS-c is a mitochondrial-derived peptide that activates AMPK, the same metabolic switch exercise and fasting flip, improving insulin sensitivity, mitochondrial function, and metabolic flexibility
For regular customers, sample fee and shipping fee are covered by us
When weight is lost quickly, the liver secretes extra cholesterol into bile, and reduced gallbladder motilitypartly due to the drug's effect on gastric emptyingcan lead to bile stasis
Standard 4-Step Escalation Schedule | Week Range | Dose | Clinical Decision Point | |---|---|---| | Weeks 1 to 4 | 2 mg SC once weekly | Assess nausea, vomiting, GI tolerability | | Weeks 5 to 8 | 4 mg SC once weekly | Hold if nausea grade 2 persists | | Weeks 9 to 12 | 8 mg SC once weekly | Check fasting glucose, LFTs at week 12 | | Weeks 13 to 24 | 12 mg SC once weekly (target) | Confirm tolerability before locking dose | Patients who cannot tolerate the step-up to 8 mg may remain at 4 mg for an additional 4 weeks before retrying escalation
US$ 21.64
US$ 21.52
US$ 25.73
US$ 28.96
US$ 24.45
US$ 24.51
US$ 21.99
US$ 22.12
